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ABSTRACT 
 
 
Determining the Knowledge and Attitudes of 18- to 26-Year-Old Women 
 
Regarding Cervical Cancer, Human Papillomavirus, and the 
 
Human Papillomavirus Vaccine 
 
 
by 
 
 
Ashlee Cooper Holguin, Master of Science 
 
Utah State University, 2009 
 
 
Major Professor: Phillip J. Waite, Ph.D. 
Department: Health, Physical Education, and Recreation  
 
 
This study applied the constructs of the health belief model (HBM) to assess 
women’s knowledge and attitudes (i.e., perceived susceptibility, perceived severity, 
perceived benefits and perceived barriers) regarding cervical cancer, HPV, and the HPV 
vaccine and determine whether they predict women’s intentions to receive the HPV 
vaccine. Women aged 18 to 26 years were surveyed from a convenience sample, and 
were primarily well-educated White women. Using Polytomous Universal Model 
(PLUM) ordinal regression, it was determined that the constructs of this model could not 
predict women’s intentions of receiving the HPV vaccine.  
(81 pages) 
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CHAPTER I 
 
INTRODUCTION 
 
 
According to the U.S. Cancer Statistics: 2003 Incidence and Mortality report, 
11,820 women were diagnosed with cervical cancer in 2003, and 3,919 women died from 
the disease that same year (Centers for Disease Control and Prevention [CDC], 2007). 
The American Cancer Society (ACS, 2007) predicts that there will be about 11,150 new 
cases of invasive cervical cancer in the United States in 2007. Human papillomavirus 
(HPV), the most common sexually transmitted infection (STI) in the U.S. and worldwide 
(CDC, 2006; Denny-Smith, Bairan, & Page, 2006), is present in nearly 100% of women 
with cervical cancer and is considered to be the primary cause of cervical cancer (Sharpe, 
Brandt, & McCree, 2005).  
Women at most risk for HPV infection are those who are aged 20-24 years, have 
had multiple sexual partners, or had their first sexual contact at a young age. 
Subsequently, women who smoke are at greater risk of contracting HPV infection than 
women who do not smoke (CDC, 2006).  
Practicing safe sex, regular screening tests, and vaccination are the best ways to 
prevent the development of cervical cancer (Hayden, 2006). Acquiring knowledge about 
HPV and its role after an abnormal screening test can reduce the incidence and mortality 
related to cervical cancer and other cancers (Likes & Itano, 2003). Recent national 
surveys of women have found somewhat higher rates of HPV awareness in comparison to 
previous years, although the majority of women are still unaware of HPV and its link to 
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cervical cancer (Denny-Smith et al 2006; Friedman & Shepeard, 2006; Ingledue, Cottrell, 
& Bernard, 2004).  
The American Academy of Pediatrics (AAP), CDC, and The American Academy 
of Family Physicians (AAFP) have stated the HPV vaccine, Gardasil, is now 
recommended for 11- to 12-year-old girls, but can be administered to girls as young as 9 
years of age, and may prevent the development of HPV and cervical cancer (CDC, 2006). 
The vaccine is also recommended for 13- to 26-year-old females who have not yet 
received or completed the vaccination series (CDC).  
Although knowledge is not a direct predictor of health behavior, health behavior 
theories posit that it is a distal factor (Tiro, Meissner, Kobrin, & Chollette, 2007). The 
Health Belief Model (HBM, 2002) posits that a person’s intention to perform a given 
preventative behavior is influenced by one’s knowledge of a disease threat and one’s 
attitudes regarding that disease (Rosenstock, 1974). In particular, a person’s attitudes 
regarding a particular disease threat involve one’s perceptions regarding their individual 
susceptibility to the disease, the severity of the disease, the benefits of performing the 
preventative behavior and the barriers that may place constraints on performing the 
preventative behavior. To date, no theory-driven research has been conducted aimed at 
assessing 18- to 26-year-old Utah women’s knowledge and attitudes toward cervical 
cancer, HPV, and the HPV vaccine. A clearer understanding of these factors may 
improve health professionals’ ability to design interventions that are more effective at 
increasing vaccination rates.  
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Purpose of the Study 
 
 
This study applied the constructs of the HBM to assess women’s knowledge and 
attitudes (i.e., perceived susceptibility, perceived severity, perceived benefits and 
perceived barriers) regarding cervical cancer, HPV, and the HPV vaccine and determine 
whether they predict women’s intentions to receive the HPV vaccine. The construct “cues 
to action” was excluded from this study, as the researcher is not interested in determining 
what cues women to action, but rather only determining their knowledge and attitudes. 
The sample was composed of 18- to 26-year-old women because this is the age when 
most women start to become sexually active. For the purpose of this study, pregnant 
women were not included simply because their opinions may differ from the rest of the 
population, because they are not recommended to receive the HPV vaccine, according to 
various sources (ACS, 2007; CDC, 2007).  
 
Research Questions 
 
 
The following research questions were addressed in this study: 
1. How accurate is 18- to 26-year-old women’s knowledge regarding cervical 
cancer, HPV, and the HPV vaccine? 
2. Do 18- to 26-year-old women believe there are severe consequences to getting 
HPV and cervical cancer? 
3. Do 18- to 26-year-old women believe they are susceptible to getting HPV and 
cervical cancer? 
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4. What do 18- to 26-year-old women perceive as barriers to obtaining the HPV 
vaccination? 
5. What do 18- to 26-year-old women perceive as benefits to obtaining the HPV 
vaccination? 
6. Do 18- to 26-year-old women’s knowledge levels and attitudes (i.e.,  
perceived susceptibility, perceived severity, perceived barriers, and perceived benefits) 
regarding HPV and cervical cancer predict their intention to receive the HPV 
vaccination? 
 
Limitations 
 
The following limitations existed within the study: 
1. An assumption of this study was that participants would provide accurate, 
honest responses reflecting their knowledge, attitudes and perceptions when completing 
the self-report survey.  
2. Study participants were volunteers, which may have produced slightly 
different results than if they were randomly selected from the target population.  
 
Delimitations 
 
 
The following delimitations exist within this study. 
 
1. Only women aged 18-26 years old were allowed to participate in the study.  
2. Pregnant women were excluded.  
3. Regional data may not be representative of all Utah women.  
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Definition of Terms 
 
 
Below is a list of terms defined for the purpose of this research study. 
Perceived susceptibility: The degree to which an individual feels personally 
susceptible to contracting a condition (Bandura, 1986).  
Perceived severity:  The degree to which an individual values the condition as 
serious; through emotional arousal or consideration of the consequences of the condition 
(Bandura, 1986).  
Perceived benefits: The degree to which an individual believes that taking a 
specific action to prevent a condition will be beneficial and effective (Bandura, 1986).  
Perceived barriers: The degree to which negative aspects of an action serve as 
barriers to action, causing avoidance (Bandura, 1986).  
Cues to action: Triggers that prompt an individual to action (Bandura, 1986).  
Other variables: Demographic, sociopsychological and structural variables that 
make up an individual’s perceptions of susceptibility, severity, benefits, and barriers 
(Bandura, 1986).  
Self-efficacy: An individual’s confidence that he or she can take action 
successfully (Bandura, 1986).  
Human papillomavirus (HPV): Most commonly sexually transmitted infection 
among adolescents and young adults, causing approximately 70% of all cervical cancer 
cases (Hoover, Carfioli, & Moench, 2000).  
HPV vaccine: A vaccination series approved by the Food and Drug 
Administration (FDA) for 9- to 26-year-old females (CDC, 2007)  
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Squamous cell carcinoma:  A carcinoma that is made up of or arises from 
squamous cells (Merriam Webster Online Dictionary, 2007) 
Adenocarcinoma: a malignant tumor originating in glandular epithelium (Merriam 
Webster Online Dictionary, 2007) 
Precancerous lesion: Changes in cells that may, but do not always, become 
cancer (ACS, 2007) 
Invasive cancer: Cancer that has spread beyond the layer of cells where it first 
developed to involve adjacent tissues (ACS, 2007)  
Quadrivalent: Vaccine that is highly efficacious in the prevention of persistent 
HPV infection, cervical cancer lesions, and genital warts due to HPV 6, 11, 16, or 18 
(Barclay & Murata, 2007).  
  
Summary 
 
This chapter provided a brief review of relevant research to the current study. 
Also included in the chapter were research questions, limitations, and delimitations. A 
definition of terms is also included. Chapter II will provide a more complete review of 
the current literature supporting the need for this study. Chapter III will outline the 
methodology of the study.  
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
 
Introduction 
 
 
This chapter provides an extensive review of the current literature regarding 
cervical cancer, the HPV, the HPV vaccine and the HBM. It will include sections on (a) 
the natural history of cervical cancer, (b) higher-risk populations for cervical cancer, (c) 
current screening recommendations, (d) barriers to screening (e) the nature of the virus 
and infection, (f) the vaccine and recommendations for use, (g) knowledge and attitudes 
regarding cervical cancer, HPV, and the HPV vaccine, and (h) the use of the HBM in 
exploring women’s perceptions regarding cervical cancer, HPV, and the HPV vaccine 
and their intentions to receive the vaccine.  
 
Natural History of Cervical Cancer 
 
 
Cervical cancer is rated the second most common malignant tumor globally, and 
is etiologically linked to HPV infection (Ledwaba, Dlamini, Naicker, & Bhoola, 2004). 
Worldwide, nearly 250,000 women die of cervical cancer annually (Chandler, 2006; 
Robb-Nicholson, 2007). The ACS (2007) predicts that there will be approximately 
11,150 new cases of cervical cancer in the United States in 2007, of which 3,670 will 
lead to death. Current research identifies risk factors for the disease including 
inadequately screening for HPV, having multiple sexual partners, and early onset of 
sexual activity (CDC, 2006; Ledwaba et al.).  
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Cervical cancer begins in the lining of the cervix and gradually develops from 
precancerous lesions to invasive cancer over time (ACS, 2007). Two types of cervical 
cancer include squamous cell carcinomas and adenocarcinomas, classified by how the 
cells look under a microscope. Approximately 80% to 90% of cervical cancers are 
classified as squamous cell carcinomas, which are composed of cells that resemble the 
flat, thin cells that cover the surface of the endocervix (ACS). Precancerous lesions are 
diagnosed more frequently than invasive cervical cancer and can easily be detected early 
with routine screening tests. The diagnosis of cervical cancer can be staged in order to 
determine how far the cancer has spread. The International Federation of Gynecology and 
Obstetrics (FIGO) Systems of Staging is used to classify the disease in stages 0 through 
IV (ACS). The ACS defines the stages as follows. 
Stage 0 indicates superficial cancer that is only found in the cells lining the 
cervix, not near the deeper tissues of the cervix. Stage I cancer has invaded the cervix, 
but it has not spread anywhere else. This stage is further categorized into IA, IA1 and 
IA2. Stage IA is the earliest form of stage I. There is only a small amount of cancer and it 
can only be seen under a microscope. Stage IA1 signifies the area of invasion is less than 
3 mm deep and less than 7 mm wide, whereas in stage IA2, the area of invasion is 
between 3mm and 5 mm deep and less than 7 mm wide. Then, stage IB is introduced and 
further categorized into IB1 and IB2. In stage IB, the cancer usually can be seen without 
a microscope. This stage also includes cancers that have spread deeper than 5 mm into 
connective tissue of the cervix or are wider than 7 mm and can only be seen using a 
microscope. Stage IB1 signifies the cancer is visible, but no larger than 4 cm and stage 
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IB2 means the cancer is visible and larger than 4 cm (ACS, 2007). Furthermore, stage II 
is described and categorized in stages IIA and IIB. In stage II, the cancer has spread 
beyond the cervix to nearby areas, but still inside the pelvic area. The cancer has spread 
beyond the cervix to the upper part of the vagina in stage IIA. Stage IIB indicates that 
cancer has spread to the tissue next to the cervix, also known as the parametrial tissue. In 
stage III, the cancer has spread to the lower part of the vagina or the pelvic wall. In stage 
IIIA, the cancer has spread to the lower third of the vagina, but not the pelvic wall and in 
stage IIIB, the cancer extends to the pelvic wall and/or blocks urine flow to the bladder. 
The most advanced stage of cervical cancer is stage IV, which is again categorized as 
IVA and IVB. In stage IVA, cancer has spread to the bladder or rectum; both are organs 
close to the cervix. In the final stage, IVB, the cancer has spread to distant organs beyond 
the pelvic area, such as the lungs. If cancer is detected in stage I, the chances of a woman 
living 5 years after treatment are 90-95%. If not detected until stage IV, the 5-year 
survival rate is only 20-30% (ACS).  
 
High-Risk Populations for Cervical Cancer 
 
 
Location 
 
According to the Utah Department of Health (2007), cervical cancer rates in the 
state of Utah are lower than the national rate. From 1994-2003, Utah women averaged an 
incidence rate of 6.8 per 100,000 person years compared to the national rate of 9.3 per 
100,000 person years (Hayden, 2006). Women suffering the greatest proportion of the 
disease burden in Utah are Hispanic women (Hayden).  
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Age 
 According to the surveillance epidemiology end report (SEER) from 2000-2004, 
the median age at diagnosis for cancer of the cervix was 48 years of age (National Cancer 
Institute [NCI], 2007b). Approximately 0.1% of women were diagnosed under age 20; 
15.5% between 20 and 34; 26.2% between 35 and 44; 23.3% between 45 and 54; 15.1% 
between 55 and 64; 10.3% between 65 and 74; 7.0% between 75 and 84; and 2.5% 85+ 
years of age. Another sub group at risk for HPV and cervical cancer is college women. 
College-aged women are at greater risk of contracting sexually transmitted infections 
than the general population because of the high-risk sexual behaviors in which they 
engage (Ingledue et al., 2004).  
 
Race/Ethnicity 
 The diagnostic rate of Hispanic women was 13.8 per 100,000 women indicating 
the highest rate among all ethnicities. African American women had a rate of 11.4 per 
100,000 cases diagnosed while White women had 8.5 per 100,000 cases (NCI, 2007a).  
Fortunately, the number of cases diagnosed is much more than actual death rates among 
women. From 2000-2004, the median age at death for cancer of the cervix was 57 years 
of age. Although Hispanic women have the highest rate of cases diagnosed, African 
American women have the highest death rate of cervical cancer. Hispanic women’s death 
rates are 3.3 per 100,000 deaths and African American women are 4.9 per 100,000 
deaths. White women have the lowest death rate representing 2.3 per 100,000 deaths 
(NCI).  
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Income 
  Poor women in rural areas are especially vulnerable to HPV infection and cervical 
cancer because of low access to regular gynecological care and subsequently low access 
to timely follow-up care to irregular Papanicolaou (Pap) test results and HPV positivity 
(Sharpe et al., 2005). In a study conducted by Radecki-Breitkopf, Pearson, and Breitkopf 
(2005), 338 women undergoing cervical cancer screening at two clinics in Texas were 
surveyed on their knowledge of Pap testing. Overall, minority women and those of low 
socioeconomic status had (SES) poor understanding of Pap testing, thus making them a 
very vulnerable population. According to Radecki-Breitkopf and colleagues, it is 
important to evaluate the knowledge base and informational needs of women of lower 
socioeconomic status, to ensure that they will continue screening as recommended, 
despite financial hardships.  
 
Current Screening Recommendations 
 
Cervical cancer screening using the Pap test is a low cost, effective screening test 
for preventing invasive cervical cancer (CDC, 2006). The Pap test was named after Dr. 
George Papanicolaou more than 50 years ago and was called a Pap smear prior to being 
called a Pap test (Mayo Clinic, 2007). The test is a simple procedure that collects cells 
from the cervix and the narrow, lower end of the uterus using an instrument called a 
speculum. After scraping the cells, physicians would then “smear” the cells onto a glass 
slide, hence the name Pap smear. Currently, the cells are transferred in a liquid filled tube 
and sent to a laboratory for testing (Mayo Clinic). The test effectively detects cervical 
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cancer and any changes in cervical cells that may suggest future cancer development 
(Mayo Clinic).  
 Pap tests should be performed during a pelvic examination at a clinical visit with 
any knowledgeable health care provider, and the health care provider should discuss the 
importance of the exam as a means to detect cervical cancer (CDC, 2006). Important 
considerations to follow, according to the CDC includes: (a) pap tests should not be 
considered a screening test for STI’s; (b) all women should be considered for cervical 
cancer screening, regardless of their sexual orientation; (c) women who have had a total 
hysterectomy do not require a routine Pap test unless the hysterectomy was performed 
because of cervical lesions; and (d) pregnant women should have a Pap test as part of 
routine prenatal care.  
Both the ACS and American College of Obstetricians and Gynecologists (ACOG) 
currently recommend annual Pap test screening for women 21-30 years and then every 2-
3 years for women older than 30 if three consecutive annual pap tests are negative (CDC, 
2006). Women that are 70 or older can stop having pap tests if they have had three 
normal tests in a row over the past ten years (Mayo Clinic, 2007).  
 
Barriers to Screening 
 
Today, as many as 82% of U.S women report having been screened with a Pap 
test in the past 3 years (CDC, 2006). Despite this, screening programs are not reaching all 
women in the U.S. It is estimated that half of the women diagnosed with cervical cancer 
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have never been screened for cervical cancer, and an additional 10% have not been 
screened in the past 5 years (CDC).  
An interesting study was done by McGarvey and colleagues (2003) on cancer 
screening practices and attitudes comparing women in three different ethnic groups. A 
total of 78 low-income Hispanic, Vietnamese, and Cambodian American women over 
age 40 volunteered to be interviewed in their native language. The HBM scales for 
measuring beliefs related to breast cancer (Champion, 1993) were used to assess the 
participants’ attitudes regarding risk of breast and cervical cancer and participation in 
breast cancer screening behaviors. The women were asked questions related to their 
perceptions of being susceptible to cancer, benefits of screening and barriers to screening. 
Useful information was provided implying that all three samples of women were more 
likely to perceive barriers to having a mammogram performed compared to 
nonminorities. Interestingly, health beliefs were more similar among Hispanic and 
Vietnamese women than Vietnamese and Cambodian women. Approximately 72% of 
Hispanic women and 69% of Vietnamese women reported that cost and lack of insurance 
coverage were reasons for not being screened. Cambodian women cited lack of 
transportation (38%) and language barriers (46%) as reasons for not being screened. In 
addition, Cambodian women also mentioned that they believed screening was 
unnecessary due to their older age and lack of sexual activity, a belief not indicated by 
either of the other groups. Education about cancer screening in itself can be an effective 
outreach strategy for women of all ethnicities, according to researchers (McGarvey et 
al.).  
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Several recent studies suggest a strong association between obesity and receipt of 
cancer screening practices (Ferrante, Chen, & Jacobs, 2006; Fontaine, Heo, & Allison, 
2001; Ostbye, Taylor, Yancy, & Krause, 2005). Ferrante and colleagues conducted a 
study on breast and cervical cancer screening in 1,809 obese minority women using 
survey data from a retrospective chart review of women in three urban areas of New 
Jersey. Information abstracted from the charts included demographic data, exclusionary 
conditions, and other factors that might influence breast or cervical cancer screening 
(weight, age, ethnicity, smoking status, educational status, family history of breast or 
cervical cancer, and chronic medical conditions). The main outcome variables were up-
to-date mammography and Pap test screenings. The main independent variable was 
obesity, which was defined as having a body mass index kg/m2 >30 kg. Surprisingly, 
results from this study indicated that there was not a difference in mammography rates 
among obese and nonobese women. However, obese women were less likely to be up-to-
date in Pap test screenings. Further studies are needed to determine barriers and effective 
interventions to improve screening in obese minority women (Ferrante et al.).  
Fontaine and colleagues (2001) complied data from the Behavioral Risk Factor 
Surveillance System (BRFSS), a nationwide telephone survey, on body weight and 
cancer screening among more than 80,000 women. Subjects were categorized as 
underweight, desirable weight, overweight, obese class I, obese class II, and obese class 
III. The outcome measure of their study was number of years since the women’s most 
recent Pap screening test, mammography and clinical breast examination (CBE). Factors 
such as age, race, smoking status and health insurance were adjusted accordingly. 
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Multiple logistic regressions were calculated for each of the three outcome variables. 
Overall, 82% of the subjects reported having obtained a Pap screening test within the 
previous 2 years. Surprisingly, the results also indicated that the relationship between 
BMI and screening was significantly different between White and Non-White 
participants on CBE, but not for Pap smear or mammography. These data are important 
in indicating that weight may be a strong correlate of screening behavior, particularly 
among white women. Again, understanding this correlation is essential in designing 
interventions to promote cancer screening in high-risk populations (Fontaine et al., 2001).  
Ostbye and colleagues (2005) completed another study on the associations 
between obesity and receipt of screening mammography, Pap tests and influenza 
vaccinations; compiling results from the Health and Retirement Study (HRS) and the 
Asset and Health Dynamics Among the Oldest Old (AHEAD) Study. The researchers 
evaluated the association of BMI and screening practices among middle-aged women and 
influenza vaccination among the elderly. The HRS included 4,439 women aged 50-61 
years of age and the AHEAD included 4,045 women and 2,154 men aged 70 years or 
more. The data obtained from these surveys indicated when BMI was >18.5 kg; there was 
indeed a relationship between BMI and Pap test screenings among middle aged white 
women, but not black women. They also found a similar association between BMI and 
influenza vaccination among the elderly. The HRS and AHEAD did not include measures 
of the health beliefs, attitudes or cultural views of subjects regarding obesity and medical 
and preventative services. As past research has declared, cultural sensitivity is an 
important factor in predicting screening behaviors (Ostbye et al.).  
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Human Papillomavirus 
 
HPV infection poses a significant public health concern (Beatty, O’Connell, 
Ashikaga & Cooper, 2003; CDC, 2006). Genital HPV infection is the most common 
sexually transmitted virus in the United States, causing genital warts, cervical cell 
abnormalities and cervical cancer in women (Friedman & Shepeard, 2006). Roughly, 20 
million Americans are currently infected with HPV and an additional 6.2 million become 
newly infected each year. It is so prevalent that most sexually active adults will have 
become infected with HPV sometime in their lives; although most will never even know 
it because it is asymptomatic (Friedman & Shepeard).  
The majority of HPV infections are asymptomatic and resolve on their own 
without clinical consequences (Friedman & Shepeard, 2007). Nonetheless, some HPV 
infections do contribute to the development of cervical cancer.  
 
Nature of Virus and Infection 
Likes and Itano (2003) described HPV as a small, double stranded DNA virus that 
is epitheliotrophic, meaning it has a special affinity for epithelial cells. HPV infects 
certain types of epithelium, such as epithelium in the genital area and the head and neck. 
Of the more than 100 types of papillomaviruses, about 40 affect the genital tract, whereas 
the rest infect skin on other areas of the body, such as the hands and feet (Likes & Itano). 
Although, it is fair to say that HPV is not just a sexually transmitted infection, the 
majority of cervical cancer cases are associated with sexual or skin to skin contact (CDC, 
2006; Ingledue et al., 2004).   
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HPV Strains 
There are many different types of human papillomaviruses that are associated 
with a wide variety of tumors. Some tumors are harmless or benign such as warts, and 
others are malignant or cancerous (Mays et al., 2000). Genital HPV can be divided into 
“high risk” (oncogenic or cancer-associated) types and “low risk” (nononcogenic; non 
cancerous) types (CDC, 2006). HPV 16 and 18 are the most common high risk types 
found in cervical cancer, while HPV 6 and 11 are the most common low risk types found 
in genital and respiratory tract warts (CDC).  
 
Human Papillomavirus Vaccine 
 
 In June of 2006, the FDA licensed the first vaccine developed to prevent cervical 
cancer and other diseases in females caused by certain types of HPV in the United States 
(CDC, 2006). On June 29, 2006, the Advisory Committee on Immunization Practices 
(ACIP) voted to recommend use of the vaccine called Gardasil, manufactured by Merck 
Pharmaceuticals, in 9- to 26-year-old females (CDC, 2006). This quadrivalent vaccine, 
made from noninfectious HPV-like particles, protects against four HPV strains (6, 11, 16, 
18), which are responsible for 70% of cervical cancers and 90% of genital warts. 
According to the CDC (2007), studies have found the vaccine to be almost 100% 
effective in preventing diseases caused by the four HPV types covered by the vaccine; 
including precancers of the cervix, vulva and vagina, and genital warts. The vaccine has 
mainly been studied in young women who have not been exposed to any of the four HPV 
types in the vaccine. The vaccine was found to be less effective in young women who 
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had already been exposed to one of the HPV types covered by the vaccine. This vaccine 
does not treat existing HPV infections, genital warts, precancers or cancers.  
Additional research is currently underway and various clinical trials have indicated 
promising results. For instance, the NCI stated that their research team followed young 
women (average age 23) who had received three doses of either an experimental HPV 
vaccine or a placebo between 2000 and 2003 while participating in an earlier study by the 
same researchers (NCI, 2007b). The earlier study showed that the experimental vaccine 
prevented most infections with HPV-16 and HPV-18, the two types of HPV that cause 
most cases of cervical cancer. The vaccine also partly protected many women from two 
other strains of HPV, HPV-45 and HPV-31, which are the third and fourth most common 
HPV types associated with cervical cancer. None of the women who were vaccinated 
reported any serious side effects from the medication. However, public health officials 
note that this vaccine will not replace other prevention strategies since it will not work to 
prevent all genital HPV strains to which people may become exposed (CDC, 2007).  
 
Current Recommendations for Vaccination 
 
The AAP, the ACIP of the Centers for Disease Control, and the AAFP have 
produced a recommended immunization schedule for children and adolescents (AAP, 
2007) living in the United States. The schedule reflects the addition of the HPV vaccine 
for girls 11-12 years of age whom have not yet become sexually active, with “catch up” 
vaccines for girls 13-18 years of age (AAP). Pichichero (2007) stated that the vaccine is 
also recommended for women up to 26 years old and/or women who have received or 
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completed the vaccination series. The FDA is currently examining the effectiveness of 
the vaccine for women over 26 years old, but the conclusions of this examination could 
take up to five years (Pichichero).  
The vaccination series consists of three intramuscular injections at 0 months, 2 
months, and 6 months (AAP, 2007). Current research indicates the vaccine is not 
recommended for pregnant women or women already infected with HPV (Robb-
Nicholson, 2007).  
 
Knowledge and Attitudes Regarding Cervical Cancer, HPV,  
 
and HPV Vaccination 
 
 
Currently, there is an abundance of research on U.S. women’s knowledge and 
attitudes regarding HPV, its link to cervical cancer and getting the HPV vaccination as a 
means to prevent infection. To date, there has been no research conducted on Utah 
women’s knowledge and attitudes regarding the above mentioned. This researcher 
identified eight relevant studies that follow below.  
Tiro and colleagues (2007) conducted a study that analyzed cross sectional data 
from women (n = 3,076) ages 18-75 years old responding to the 2005 Health Information 
National Trends Survey (HINTS). Their objective was to assess factors associated with 
U.S women’s awareness of HPV and knowledge about its link to cervical cancer. The 
HINTS 2005 included items that assessed sociodemographics, health status, personal and 
familial cancer history, general and specific cancer knowledge, health communication 
preferences and cancer screening behaviors.  
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Results of this study indicated that knowledge about HPV among U.S women was 
relatively low; 40% of women (n = 1,248) reported that they had never heard of HPV. 
Among those that had heard of it, less than half knew that HPV causes cervical cancer. 
Nonetheless, awareness of HPV has increased over the past decade, but knowledge of its 
link to cervical cancer remains low (Tiro et al., 2007).  
Another study conducted by Sharpe and colleagues (2005) explored women’s 
knowledge and understanding of abnormal Pap tests and HPV. The study was part of a 
five site initiative funded by the CDC to investigate women’s knowledge and experience 
with HPV and its impact on their lives to guide the development of educational messages. 
Forty-four in depth interviews were conducted with low-income, HPV-positive women 
ages 18-64 years. Participants were asked 19 open ended questions and audio taped with 
consent for research purposes. Of the 44 women studied, 21 reported they had been told 
of their HPV diagnosis and responded to questions about having HPV, including what 
their health care provider told them, what they would advise other women with HPV,  
and what they told family, friends and partners. The second most common theme was the 
association between HPV and cancer. While 19 women said that HPV can or does cause 
cancer, only half of these women mentioned cervical cancer specifically (Sharpe et al.).  
An interesting study was done by Hoover and colleagues (2000) on HPV vaccine 
acceptability among adolescents. The purpose of this study was to evaluate HPV 
knowledge and priorities, HPV vaccine acceptability, and willingness to participate in an 
HPV vaccination clinical trial among a group of adolescent and young adult women in 
the United States. A convenience sample of 60 women between 15 and 28 years old were 
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obtained from four sites on the Southern New Jersey Shore, which were frequently 
visited by young teens and adults. Mostly unaccompanied women or women without a 
male partner were approached and asked if they were willing to fill out a 10-15 minute 
survey as they were assured of their confidentiality. Women that agreed to participate 
read a short statement about a hypothetical vaccine trial to prevent Human 
Papillomavirus. The women then answered questions designed to assess knowledge about 
HPV, concerns about the risks of sexual activity, attitudes toward using an HPV vaccine 
and participation in an HPV vaccine trial.  
Among five potentially adverse outcomes of sexual activity, 86.6% ranked AIDS 
as their biggest concern, while 52% of the participants ranked cervical cancer as their 
second biggest concern. Only 15% of this sample indicated they would be extremely 
likely to pay for an HPV vaccine if the costs were not covered by insurance, surprisingly. 
Almost 70% felt that men should receive a vaccine against oncogenic HPV to protect 
potential sexual partners even though men do not develop cervical cancer.  
Many of the women in this study would not participate in a 3-year HPV vaccine 
clinical trial under conditions that were likely to exist as described by the interviewers. 
Less than 30% would participate in a trial that included three vaccine shots and biannual 
pelvic exams. Various reasons were listed in relation to non-participation in a clinical 
trial such as time, inconvenience and embarrassment of getting pelvic exams.  
Although knowledge of HPV was low in this group, and many did not agree to 
take part in a 3-year vaccine trial, these women were very concerned about cervical 
cancer and genital warts. The researchers concluded by emphasizing the importance of 
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increased education of HPV in American high schools. Researchers feel it may not be 
very hard to convince adolescent women of the importance of the HPV vaccine, but 
rather hard to convince parents and community members (Hoover et al., 2000). 
Hopenhayn, Christian, Christian, and Schoenberg (2007) conducted a similar 
study on the attitudes aimed at the Human Papillomavirus vaccine in two Appalachian 
Kentucky counties. Approximately 629 women were randomly telephoned and surveyed 
on HPV vaccine acceptance for themselves and for adolescent girls. In these particular 
counties, cervical cancer incidence and mortality rates are among the highest in the 
United States. To participate in the survey, participants had to be at least 18 years of age 
and could not have undergone a hysterectomy in their past. Survey topics included Pap 
test knowledge and practices, awareness of HPV, acceptability of HPV testing and 
vaccination, smoking behavior and demographic information. The survey sample was 
first characterized by univariate analysis, with respect to few basic descriptive 
characteristics such as race, income, education and current smoking status. Bivariate and 
multivariate analyses were conducted for the majority of HPV and HPV vaccine 
acceptability questions. In terms of knowledge of HPV, 44.4% of the respondents stated 
they had heard of HPV from either a health professional or by the media. Although 
acceptance of HPV vaccine varied across age groups, the majority of women in this study 
indicated interest in receiving an HPV vaccine (85.2%). Overall, the acceptance of a 
vaccine to prevent HPV decreased with age. Also of interest, women who had never been 
married or women who were widowed were less likely to accept the HPV vaccine. 
Nonetheless, women in the middle-income groups showed higher acceptability toward 
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the HPV vaccine, as did women without health care coverage and women who smoke. 
When demographic variables were entered into a logistic regression analysis for vaccine 
acceptance, age and smoking, all remained statistically significant (p < 0.05).  
In comparison to recently published studies, these researchers indicate that 
participants in this study were more aware of the existence of HPV, both nationally and 
internationally. A somewhat surprising result was that smoking behavior was the 
strongest predictor of HPV vaccination acceptability for both the respondents themselves 
and for girls aged 10-15 years. Various reasons for this strong association is included in 
the study, possibly due to the fact that cervical cancer incidence are higher among women 
who smoke (Hopenhayn et al., 2007).  
Another study was published by researchers Ferris, Waller, Owen, and Smith 
(2008) on HPV vaccine acceptance among southern U.S., mid-adult women. Although 
the vaccine is currently recommended for 9-26 year old women, mid-adult women (>27 
years old) have expressed a keen interest in receiving the vaccine to stay healthy and 
lower their risk of cervical cancer and genital warts.  
A convenience sample of 472 mid-adult women completed a survey that included 
demographics, knowledge, and behavioral variables as potential correlates of vaccine 
acceptance. An inclusion limit of women older than 25 years was considered, and this 
range was selected before FDA approval for current vaccination recommendations. 
Survey participants first completed a 46 question (preintervention) survey and received a 
one-page educational pamphlet with information about HPV and HPV vaccines. Then, 
participants completed another 23 question (postintervention) survey. Both univariate and 
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multivariate analyses were completed for demographics, knowledge and behaviors. For 
knowledge and behaviors before intervention, knowledge that HPV causes cervical 
cancer and knowledge of being at risk for HPV infection were significant correlates of 
wanting the HPV vaccine after intervention (p = .001). Mid-adult women with a history 
of an abnormal Pap test also expressed various motives for wanting the vaccine. The 
results of this study reinforce the necessity of education aimed at mid adult women on 
HPV and HPV vaccines.  
Holcomb, Motino Bailey, Crawford, and Ruffin (2004) conducted a similar study 
assessing the knowledge and behaviors related to HPV infection in 289 adult men and 
women in the state of Michigan. Sample participants were derived from a student health 
clinic and two community based family practice clinics. Participants were asked to 
complete a 52-item questionnaire, which included information about demographics, HPV 
knowledge, sexual history, attitudes towards sexually transmitted infections, and what 
participants would do if they or their partner were diagnosed with HPV. As prior research 
has indicated, this study also suggests knowledge about HPV among this sample was 
low, with 12% having never heard of genital warts, and 33% having never heard of HPV 
before. Knowledge scores were significantly different between groups classified by 
gender (p = .001) and marital status (p = .001). However, knowledge scores were not 
significantly different between ethnic groups, sexual preference, age at first intercourse, 
and smoking status. Holcomb and colleagues discussed the fact that poor knowledge is 
not just limited to college-age adults, as this study involved participants from community 
based family practice clinics. The authors concluded that it is unknown whether 
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increasing awareness and knowledge of HPV would change adults’ participation in risky 
sexual behaviors (Holcomb et al.).  
Researchers from New Mexico State University and Hospital de la Familia in 
Ciudad Juarez, Mexico (just across the U.S. border) implemented a descriptive pilot 
study to (a) assess the willingness of women residing in Ciudad Juarez to use the HPV 
vaccine, evaluate their perceptions about the HPV vaccine, and determine possible 
barriers to vaccine acceptance and compliance, and (b) use the respondent responses to 
develop appropriate research questions for the main study (Moraros et al., 2006). The 
pilot study included a 25-item questionnaire and explored the views of 60 adult Mexican 
women, all of whom were mothers of adolescent girls between 10-14 years of age, on 
four interest areas: HPV knowledge, HPV vaccine knowledge and attitudes, barriers to 
vaccine use and perceived potential side effects of the HPV vaccine. In this study, only 
7% of respondents knew that HPV was a virus or STI. Nearly 90% (n = 50) had not heard 
of the HPV vaccine, but 62% of those believed a vaccine would prevent HPV infection. 
Surprisingly, 38% said their church would not approve of HPV vaccination among 10-14 
year old girls. It is quite evident that from this study that the effectiveness of such a 
vaccine on the US-Mexico border will depend on the willingness of the mainly Hispanic 
population of interest to accept and use the HPV vaccine. Appropriately designed 
culturally sensitive interventions will indeed help increase knowledge and awareness of 
HPV and the HPV vaccine (Moraros et al.).  
Another study regarding HPV education in middle and high schools of Vermont 
was conducted by Beatty, O’Connell, Ashikaga, & Cooper (2003). A survey instrument 
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was developed by the HPV Working Group and the Fletcher Allen Health Care, 
University of Vermont and the Vermont Cancer Center to provide baseline information 
on the status of HPV education in middle and high schools in Vermont. The 17-question 
survey was based on the PRECEDE-PROCEED planning model used to describe factors 
that may contribute to a health problem within a community. Surveys were mailed to 
Vermont public middle school and high school nurses and educators. One hundred eight 
surveys were returned (n = 108); 61% were received from high schools and 39% were 
received from middle schools. The survey resulted in some interesting findings stating 
that 62% of respondents indicated insufficient time was spent teaching about HPV. 
Enabling factors such as resources, student interest and school support were identified, 
with only 13% of respondents indicating that they had the resources for teaching about 
HPV. Less than half of respondents (37%) felt that students wanted to know about HPV 
and slightly more than half (55%) of the respondents reported that school policies 
supported the respondent’s ability to teach about HPV and other sexually transmitted 
infections.  
Overall, HPV/STI education was not being implemented in Vermont public 
schools for a variety of reasons. Respondents’ main concern was “not enough class time” 
and “not knowledgeable enough to teach the subject.”  The researchers acknowledged 
that results from this survey underscore a need for including HPV education materials to 
adolescents in middle schools and high schools (Beatty et al., 2003).  
The above-mentioned studies indicate that adolescents and young women in the 
United States are uninformed about cervical cancer, HPV, and the HPV vaccine. Various 
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reasons cited were personal beliefs, vaccine acceptability, and minimal availability of 
educational materials in public schools.  
 
Health Belief Model 
 
The HBM was developed in the 1950s by psychologists Hochbaum, Rosenstock 
and Kegels from the U.S. Public Health Service to help explain why people would or 
wouldn’t use health services (Rosenstock, 1974). The HBM indicate that health behaviors 
are determined by health beliefs and readiness to take action (Abood, Black, & Feral, 
2003).  
The HBM is the most widely used model of health behavior and has been applied 
in a number of contexts, including: use of preventative screenings, obtaining 
immunizations, compliance with medical regimens and response to illness symptoms 
(Bish, Sutton, & Golombok, 2000). The HBM has been expanded, broken down into 
components, compared to other frameworks and analyzed using a wide variety of 
multivariate techniques (Rosenstock, 1974). The components of the model include; 
perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cues 
to action, other variables and self efficacy (Rosenstock).  
Perceived susceptibility refers to one’s subjective perception of the risk of 
contracting any given health condition. In a medical context, this includes the acceptance 
of any diagnosis, personal estimates of resusceptibility and susceptibility to the illness in 
general (Rosenstock, 1974). Perceived severity refers to one’s feelings concerning the 
seriousness of contracting any given health condition, or leaving it untreated, and 
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possible social consequences. The combination of susceptibility and severity has been 
referred to as perceived threat (Rosenstock). Perceived benefits refer to one’s knowledge, 
attitudes or beliefs of a particular course of action that can be taken to reduce risk of 
disease or illness. Included in this construct are health-related benefits as well as non-
health related benefits. An example of a non-health related benefit is getting vaccinated 
because your insurance company will cover the cost, rather than getting vaccinated to 
decrease risk of illness (Rosenstock). A perceived barrier refers to one’s beliefs about the 
tangible and psychological costs of the advised action. Common barriers to proper health 
care include; inconvenience, cost, time-consumption and so forth. An example of a 
perceived barrier to getting vaccinated might be inconvenience of the location of the 
clinic (Rosenstock). Cues to action is not an original component of the HBM, but rather 
added to the model over the years. It refers to the point in one’s life in which they decide 
to take action towards any given health behavior. Many things may contribute to this 
decision, such as acquiring an illness, trying to please a friend or family member or even 
media publicity. One must have perceptions about the susceptibility and seriousness of an 
illness, and understand the barriers and benefits of making changes to their health 
behavior prior to taking action (Rosenstock). As is the case with many other theories and 
models, there are always a few other variables to understand. In the HBM, demographic 
and sociopsychological variables may affect the individuals’ perceptions and therefore, 
indirectly influence particular health-related behaviors (Rosenstock). This is referred to 
as other variables in the HBM. The last component of the HBM is self-efficacy. This 
construct refers to “the conviction that one can successfully execute the behavior required 
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to produce the outcomes” (Rosenstock). This was added to the model after several 
investigations and years of revisions. Self-efficacy assumes that the likelihood of taking 
action is not only a function of beliefs related to outcomes, but also a function of a 
person’s belief that he/she is behaviorally capable of achieving the desired outcome 
(Abood et al., 2003).  
 
Health Belief Model used in Cervical Cancer and HPV Research 
 
The use of theories in health education studies helps guide the research and 
provides a framework for explaining the results of a study. There is a limited amount of 
research on the inclusion of the HBM in cervical cancer and HPV research.  
Ingledue and colleagues (2004) conducted a study to better understand college 
women’s knowledge, perceptions and preventative behaviors regarding Human 
Papillomavirus infection and cervical cancer. The study applied the HBM as a theoretical 
framework in determining perceived seriousness, perceived susceptibility and 
preventative behaviors regarding HPV and cervical cancer. Upon a review of the 
literature, the researchers developed a 40-item questionnaire to assess the above 
mentioned, with the assumption of obtaining accurate, honest responses from the college 
women. Approximately 1,000 full-time college women between the ages of 18-30 were 
randomly selected via the registrar’s computer at a large Midwestern university. Of the 
1,000 students selected, 428 students (n = 428) returned completed questionnaires via 
paper mail.  
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Relationships between HPV and cervical cancer knowledge and perceived 
seriousness, perceived susceptibility and preventative behaviors were examined. Using 
Pearson correlation coefficients, no significant relationship was found to exist between 
HPV and cervical cancer knowledge and perceived susceptibility to HPV or cervical 
cancer (r = .020, p = .680). A significant negative correlation was found to exist between 
HPV and cervical cancer knowledge and perceived seriousness of HPV and cervical 
cancer (r = -0.242, p = .000), indicating that as knowledge increased, perceived 
seriousness decreased. The researchers concluded that college women participating in 
this study demonstrated low levels of knowledge concerning HPV and cervical cancer 
while exhibiting high-risk sexual behaviors. Further HPV and cervical cancer research 
needs to be conducted among women of the same age group that are not part of a college 
or university community, according to this study (Ingledue et al., 2004).  
An additional study using the HBM was conducted by Denny-Smith and 
colleagues (2006). The purpose of the study was to assess knowledge of, perceived 
susceptibility to, perceived seriousness of, and risk behaviors regarding Human 
Papillomavirus and cervical cancer among female nursing students enrolled in a 
baccalaureate nursing program. The HBM was used to examine the relationship between 
people’s beliefs and health specific behaviors.  
In this study, a 40-item questionnaire was distributed to a convenience sample of 
240 female nursing students. The instrument asked questions related to awareness of 
HPV and cervical cancer as well as sexual behaviors and condom use. In this study, the 
hypotheses were tested examining the relationship between HPV and cervical cancer, 
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knowledge, perceived seriousness, perceived susceptibility, number of sexual partners 
and condom use. Using Pearson’s correlation coefficients, no significant relationship was 
found between HPV/cervical cancer knowledge and perceived susceptibility (p = .67) or 
perceived seriousness (p = .69). However, a significant positive relationship was found 
between HPV/cervical cancer knowledge and number of partners (p = .01) indicating that 
as knowledge increased, so did number of partners. Finally, a significant relationship was 
also found between susceptibility and severity of HPV and cervical cancer (p = .04) 
indicating that as perceived susceptibility increased, so did perceived seriousness. The 
researchers were surprised to find that the participating female nursing students 
demonstrated rather low knowledge levels for what one would expect from upper level 
nursing students (Denny-Smith et al., 2006).  
In conclusion, this section provided interesting hindsight regarding women’s 
knowledge and attitudes towards cervical cancer, HPV and the HPV vaccine. Women in 
the U.S lack knowledge and perceptions related to their personal susceptibility of the 
disease and their thoughts on the severity of cervical cancer as a whole.  
 
Summary 
 
This chapter provided an extensive review of current literature on cervical cancer, 
HPV, the HPV vaccine, and the HBM. Studies reported in the literature review showed 
that women in this country lack the knowledge, and have been misinformed about 
cervical cancer and/or HPV, which is affecting their perceptions towards their 
susceptibility of acquiring cervical cancer or the HPV.  
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There is a minimal amount of research on women’s thoughts towards the HPV 
vaccination as a means to prevent the virus that leads to cervical cancer and possible 
eventual death. There are also few studies that utilize the HBM in relation to HPV 
vaccine acceptance among 18- to 26-year-old women in the Western United States. The 
need for and purpose of this study has been justified based on the literature reported in 
this review. Chapter III will explain the methodology of the study.  
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CHAPTER III 
 
METHODOLOGY 
 
 
 The purpose of this chapter is to provide an overview of procedures used to guide 
this study. Information included explains research design, sample, sample demographics, 
instrumentation, data collection procedures, pilot testing, and data analysis.  
 
Research Design 
 
 A cross-sectional, quantitative study was conducted to determine the knowledge, 
attitudes, and perceptions of 18-to 26-year-old Utah women regarding cervical cancer, 
HPV and the HPV vaccine. Survey research was conducted in health clinics with a 
sample of convenience.  
 
Sample 
 
  The sample included 18- to 26-year-old women who were not pregnant. The 
subjects were obtained between June and September 2008 in various clinics throughout 
the Bear River Health District, including the Cache Valley Women’s Center, USU 
Student Wellness Center and the Logan, Brigham, and Tremonton offices of the Bear 
River Health Department (Appendix C, D, E). A power analysis was conducted at the 
Office of Methodological Data and Research (OMDR) at Utah State University, under 
the direction of Chad Bohn, to determine a suitable number of participants needed for the 
study. The analysis determined an appropriate sample size of approximately 209 study 
participants. This was based on a small effect size of .20, power of .08, and an alpha level 
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.05. The alpha level .05 was utilized because researchers believe this level is most 
suitable at determining the probability that the test will lead to a Type I error. In other 
words, this means the likelihood of obtaining sample data in the critical region when the 
null hypothesis is true (Gravetter & Wallnau, 2005).  
 The sample consisted of 212 participants. Although the majority of the sample 
(n = 172, 81.1%) were White women, Non-White Hispanics represented 9%, African 
Americans .5%, Asians 1.4%, and multiracial were 2.8% of the sample. Approximately 
5.7% of the sample indicated “other” as their race.  
 Most of the women who participated in the study (n = 90, 42.5%) stated they had 
some college as their highest level of education completed, while 31.6% had a high 
school education as their highest level completed. In this study, 11.8% of participants 
reported their highest level of education as trade school or certification program, 9.4% 
reported having completed a Bachelors degree, 4.2% less than high school and one 
participant reported having completed a post graduate degree (see Table 1).  
  
Instrumentation 
 
 
A survey was developed by the researcher for the purpose of this study. Questions 
were derived from past surveys (Denny-Smith et al., 2006; Hoover et al., 2000; Ingledue 
et al., 2004; Tiro et al., 2007) and modified to address and answer the research questions 
for this particular study (see Appendix A). The internal validity and face content of the 
survey was confirmed and peer reviewed by a panel of experts prior to pilot testing. No  
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Table 1  
Sample Demographics 
Demographic Valid N Percent 
Age                                      
 18 23 10.8 
 19 29 13.7 
 20 27 12.7 
 21 26 12.3 
 22 20 9.4 
 23 25 11.8 
 24 20 9.4 
 25 15 7.1 
 26 27 12.7 
Race   
Caucasian 172 81.1 
Non-white Hispanic 19 9.0 
African American 1 .5 
Asian 3 1.4 
Multiracial 5 2.4 
Other 12 5.7 
Education   
 Less than high school 9 4.2 
 High school 67 31.6 
 Trade school/certification  25 11.8 
 Some college 90 42.5 
 Bachelors degree 20 9.4 
 Post graduate degree 1 .5 
Note. N = 212. 
 
immediate changes were required prior to survey administration, other than rearranging 
the ordering of survey items.  
Survey items were categorized in relation to the research questions. There were 
two inclusion/exclusion items, two demographic items, six knowledge based items, one 
perceived susceptibility item, three perceived severity items, two perceived barriers 
items, and three items related to perceived benefits. A survey item assessing behavioral 
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intention to be vaccinated against HPV was also included. Knowledge survey items were 
yes/no, multiple choice, and true/false. Yes/No items were scored with Yes = 1 point and 
No = 0 points. The multiple-choice questions had only one correct answer and 
participants received one point for every correct answer. True/False items were scored 
according to the correct answer. The correct response received one point and the incorrect 
response received no point. Scores were summed at the end to calculate an overall 
knowledge score.  
The HBM items (perceived susceptibility, perceived severity, perceived barriers 
and perceived benefits and behavioral intention) were scored on a Likert type scale 
ranging from 1 to 5. As such, one represents “strongly agree,” 2 “agree,” 3 “not sure,” 4 
“disagree,” and 5 meant “strongly disagree.”  The behavioral intention was also measured 
on the same Likert type scale.  
 
Data Collection Procedures 
 
Following the Utah State University Institutional Review Board (IRB) approval, 
survey data collection began in June 2008 and concluded in September 2008. Women 
involved in the study received a brief, confidential survey along with a Letter of 
Information (see Appendix B). All women involved voluntarily completed the survey if 
they so chose. The office managers and nurses agreed to be responsible for collecting the 
surveys and ensuring they were kept in a safe, confidential place. The student researcher 
provided a box which was locked in the manager’s office at the end of each business day. 
The student researcher periodically checked in with the office manager and/or nurses to 
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verify that surveys were being collected in an appropriate fashion. These visits included a 
small gift for the office manger and nursing staff as an incentive to continue survey 
administration and assist in the data collection process.  
 
Pilot Testing 
 
Once the survey instrument was reviewed for its accuracy and proper adjustments 
were made as recommended by the expert panel, a pilot test occurred. The pilot test was 
conducted with approximately twenty 18- to 26-year-old women at the Student Health 
and Wellness Center on the campus of Utah State University in May 2008. This was 
conducted in a similar fashion to the actual survey administration that took place at the 
various clinics. Pilot testing was advantageous because it alerted the researcher to the 
idea of expanding research locations in order to obtain survey data in a reasonable 
amount of time. The pilot test, however, did not alert the researcher of any other major 
issues and no survey items were changed, added or removed from the instrument.  
 
Data Analysis 
 
Data collected from this research study were analyzed using both descriptive and 
inferential statistics utilizing SPSS software for Windows. Descriptive statistics were 
used to summarize, organize and simplify data, while inferential statistics allowed for 
generalizations to be made about the overall population from which the sample was 
selected (Gravetter & Wallnau, 2005). The calculation of descriptive statistics included 
calculating means and standard deviations. A PLUM ordinal regression was also 
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conducted to determine women’s behavioral intention to get vaccinated. In statistics, this 
is the regression model for ordinal dependent variables. It can be thought of as an 
extension of the logistic regression model for dichotomous dependent variables, allowing 
for more than two (ordered) response categories (Wikipedia, 2009). The researcher 
determined the relationship between women’s attitudes and perceptions and whether it 
predicted their intention to get vaccinated against the Human Papillomavirus. Table 2 
provides a summary of the comparisons that were made as part of this study.  
 
Summary 
 
 
This chapter explained the methodology of the study. The research design, 
sample, sample demographics, instrumentation, data collection procedures, pilot testing, 
and data analysis were all discussed in detail.  
 
Table 2 
 
Research Questions, Instrument Items, and Data Analysis 
 
Research question Instrument items Data Analysis 
How accurate is 18-26 year old women’s knowledge 
regarding cervical cancer, HPV and the HPV vaccine? 
5,6,7,8,9,10 Mean, mode, and 
standard deviation 
Do 18-26 year old women believe there are severe 
consequences to getting HPV and cervical cancer? 
12, 13,  Mean, mode, and 
standard deviation 
Do 18-26 year old women believe they are susceptible to 
getting HPV and cervical cancer? 
11 Mean, mode, and 
standard deviation 
What do 18-26 year old women perceive as barriers to 
obtaining the HPV vaccination? 
16,19 Mean, mode, and 
standard deviation 
What do 18-26 year old women perceive as benefits to 
obtaining the HPV vaccination?   
15,20 Mean, mode, and 
standard deviation 
Do 18-26 year old women’s knowledge levels and attitudes 
(i.e., perceived susceptibility, severity, barriers, benefits) 
regarding HPV and cervical cancer predict their intention to 
receive the HPV vaccination?   
18 Mean, mode, 
standard deviation, 
and PLUM ordinal 
regression 
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CHAPTER IV 
 
RESULTS 
 
 
A study was conducted, using the constructs of the HBM, to assess women’s 
knowledge and attitudes regarding cervical cancer, HPV and the HPV vaccine and to 
determine whether they predict women’s intentions to receive the HPV vaccine. This 
chapter discusses the results of the six research questions posed in Chapters I and III, and 
the results are presented below. 
 
Research Question #1 
 
 
Research question #1: How accurate is 18- to 26-year-old women’s knowledge 
regarding cervical cancer, HPV, and the HPV vaccine?  When subjects were asked if 
they had heard about HPV, most women (n = 172, 81.1%) reported they were at least 
familiar with the virus. The remaining 18.9% had not heard of the virus. When asked 
about viral transmission, nearly 63% could correctly answer how HPV is transmitted 
from one person to another when given multiple choices to choose from. The remaining 
37% could not correctly answer how HPV is transmitted. Although women seemed to be 
informed about HPV and HPV transmission, more than half of the sample (n = 122, 
57.5%) could not correctly identify proper ways of decreasing their risk of becoming 
infected with HPV. Another survey item, referencing knowledge, sought to determine 
HPV and its link to genital warts and cervical cancer. Results indicated that 76.9% of 
women in this study felt it was true that there is a link. Nonetheless, most women (n = 
168, 79.2%) could identify ways to prevent themselves from acquiring cervical cancer 
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despite their inability to identify ways to decrease their risks of becoming infected with 
the virus.  
Finally, one survey item provided that over 70% of the study participants (n= 152, 
71.7%) stated they have heard of the modern day vaccine, Gardasil, which protects 
women from common strains of HPV, while only 28.3% said they had never heard of the 
vaccine. This information is summarized as a whole in Table 3.  
 
Research Question 2 
 
Research question #2: Do 18- to 26-year-old women believe there are severe 
consequences to getting HPV and cervical cancer?  When asked if getting HPV is a 
serious health issue, approximately 80.7% of the sample reported they either strongly 
agreed or agreed that it is a serious health issue. Moreover, 4.2% either strongly  
 
Table 3 
 
Research Question #1 Results 
 
Survey item Response n Percent 
Have you heard of the Human 
Papillomavirus (HPV)? 
Yes 
No 
172 
40 
81.1 
18.9 
How is HPV transmitted from 
one person to another? 
Sexual contact+ 
Sharing a drink/through needles/don’t know 
133 
79 
62.7 
37.3 
How can you decrease your risk 
of becoming infected with HPV? 
Abstinence/sex with condom/avoid smoking 
All of the above+ 
122 
90 
57.5 
42.5 
HPV is linked to genital warts 
and cervical cancer 
True 
False 
163 
49 
76.9 
23.1 
How can you prevent yourself 
from acquiring cervical cancer? 
Safe sex/pap screenings/vaccinations 
All of the above+ 
44 
168 
20.8 
79.2 
Have you heard of a vaccine that 
protects women from common 
strains of HPV 
Yes 
No 
152 
60 
71.7 
28.3 
+Signifies correct answer 
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disagreed or disagreed that getting HPV is a serious health issue. The same question was 
posed on the seriousness of getting cervical cancer. Approximately 90% either strongly 
agreed or agreed that getting cervical cancer is a serious health issue. Those that strongly 
disagreed or disagreed represented about 5.2% of the study sample (see Table 4).  
 
Research Question 3 
 
 
Research question #3:  Do 18- to 26-year-old women believe they are susceptible 
to getting HPV and cervical cancer?  Subjects were asked if their family history puts 
them at a greater risk of acquiring HPV and/or cervical cancer. A small portion of the 
sample (n = 29, 13.6%) either strongly agreed or agreed, while slightly over 50% strongly 
disagreed or disagreed with the statement. Noteworthy results express that 35.4% were 
not sure whether their family history put them at an increased risk of getting cervical 
cancer or HPV (see Table 5).  
 
Table 4  
 
Research Question #2 Results 
 
Survey item Response n Percent  
Getting HPV is a serious health issue Strongly disagree 
Disagree 
Not sure 
Agree 
Strongly agree 
2 
7 
32 
65 
106 
.9 
3.3 
15.1 
30.7 
50.0 
Getting cervical cancer is a serious 
health issue 
Strongly disagree 
Disagree 
Not sure 
Agree 
Strongly agree 
7 
4 
10 
33 
158 
3.3 
1.9 
4.7 
15.6 
74.5 
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Table 5 
Research Question #3 Results 
Survey item Response n Percent  
My family history puts me at risk for 
getting cervical cancer and/or HPV 
Strongly disagree 
Disagree 
Not sure 
Agree 
Strongly agree  
70 
38 
75 
16 
13 
33.0 
17.9 
35.4 
7.5 
6.1 
 
 
Research Question 4 
 
 
Research question #4: What do 18- to 26-year-old women perceive as barriers to 
obtaining the HPV vaccination? To answer this research question, subjects were asked if 
they thought getting the HPV vaccination series might be unsafe or harmful to their 
health. In the current study, 15.6% either strongly agreed or agreed and 58.5% either 
strongly disagreed or disagreed. Noteworthy results express that 25.9% were not sure 
whether they thought getting the vaccine might be unsafe or harmful to them. To further 
answer this research question, subjects were also asked if they thought having a lack of 
insurance would explain why they would not or could not receive the HPV vaccination. 
About 18.9% of participants either strongly agreed or agreed with the question, while 
55.7% strongly disagreed or disagreed that lack of insurance explains why they would not 
obtain the vaccination (see Table 6).  
 
Research Question 5 
 
 
Research question #5: What do 18- to 26-year-old women perceive as benefits to 
obtaining the HPV vaccination? Subjects were also asked if they felt that getting regular 
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Table 6 
 
Research Question #4 Results 
 
Survey item Response n Percent 
I think getting the HPV vaccination 
series might be unsafe or harmful to 
my health 
Strongly disagree 
Disagree 
Not sure 
Agree 
Strongly agree 
79 
45 
55 
19 
14 
37.3 
21.2 
25.9 
9.0 
6.6 
Lack of insurance explains why I 
cannot or will not get the HPV 
vaccination 
Strongly disagree 
Disagree 
Not sure 
Agree 
Strongly agree 
88 
30 
54 
18 
22 
41.5 
14.2 
25.5 
8.5 
10.4 
 
 
pap screenings is beneficial and can detect HPV and cervical cancer. The majority of the 
sample (n = 179, 84.5%) strongly agreed or agreed with this item, while 6.1% strongly 
disagreed or disagreed.  
When asked about being informed about the benefits of getting the HPV vaccine 
from a physician or other health care professional, 56.1% of the study sample was 
uninformed, or answered no to the question. The remaining 43.9% reported that they had 
been informed about the benefits of receiving the HPV vaccine from a physician or other 
health care professional (see Table 7).  
 
Research Question 6 
 
 
Research question #6: Do 18 to-26-year-old women’s knowledge levels and 
attitudes (i.e.,  perceived susceptibility, perceived severity, perceived barriers, and 
perceived benefits) regarding HPV and cervical cancer predict their intention to receive 
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the HPV vaccination? As portrayed in Table 8, nearly 26% of women in this sample 
either 
Table 7 
Research Question #5 Results 
Survey item Response n Percent 
Getting regular pap screenings is 
beneficial and can detect HPV and 
cervical cancer 
Strongly disagree 
Disagree 
Not sure 
Agree 
Strongly agree  
9 
4 
20 
44 
135 
4.2 
1.9 
9.4 
20.8 
63.7 
I have been informed about the 
benefits of getting the HPV vaccine 
from a physician or other health care 
professional 
Yes 
No 
93 
119 
43.9 
56.1 
 
 
Table 8 
Research Question #6 Results 
Survey item Response n Percent 
I have, or will have received the HPV 
vaccination series within the next nine 
months 
Strongly disagree 
Disagree 
Not sure 
Agree 
Strongly agree  
49 
27 
81 
13 
42 
23.1 
12.7 
38.2 
6.1 
19.8 
 
 
strongly agreed or agreed that they have or will have received the HPV vaccination series 
within the next nine months. However, 35.8% strongly disagreed or disagreed that they 
would receive the vaccine. In addition, 38.2% of participants stated they were not sure if 
they would receive the HPV vaccine in the next nine months.  
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A PLUM ordinal regression was computed, to further answer this research 
question. Ordinal regression is used with ordinal dependent variables, where the 
independents may be categorical factors or continuous covariates. For this study, the 
dependant variable was women’s likelihood of getting the HPV vaccination series. The 
independent factors were knowledge levels and attitudes (i.e. perceived susceptibility, 
perceived severity, perceived barriers, and perceived benefits). 
The Cox and Snell was calculated and determined as .047. For the purpose of this 
study, this means that the independent variables (perceived susceptibility, perceived 
severity, perceived barriers, and perceived benefits) accounted for 4.7% of the variance in 
the participants’ intention toward getting the HPV vaccination. Table 9 offers a model 
summary to survey item 20.  
 In conclusion, this chapter has summarized the results of the research questions 
posed in this study. In addition, the results of the PLUM ordinal regression statistical 
analysis were explained in detail.  
 
Table 9 
Model Summary for Intention Toward HPV Vaccination 
Predictor variable B SE B Wald Β 
Knowledge -.081 .091 .791 .374 
Perceived severity .292 .186 2.470 .116 
Perceived susceptibility -.110 .106 1.074 .300 
Perceived barriers -.280 .154 3.281 .070 
Perceived benefits -.139 .136 1.049 .306 
 
 
46 
 
CHAPTER V 
 
DISCUSSION 
 
 
 The purpose of this study was to apply the constructs of the Health Belief Model 
to assess women’s knowledge and attitudes (i.e., perceived susceptibility, perceived 
severity, perceived benefits and perceived barriers) regarding cervical cancer, HPV and 
the HPV vaccine and determine whether knowledge predicts women’s intentions to 
receive the HPV vaccine. The findings of this study were compared to previous research 
as portrayed in Table 10 and discussed thereafter.  
 
Research Question #1: Accuracy of Knowledge 
 
 
Most women in the present study (n = 172, 81.1%) reported they had at least 
heard of the Human Papillomavirus. The remaining 18.9% had not heard of the virus. 
This result is much lower than previous findings by other researchers, providing some 
support for the notion that the Utah population is educated, despite its conservativeness.  
 In a study conducted by Tiro and colleagues (2007), knowledge of HPV was 
relatively low (n = 1,248, 40%) among a sample of women surveyed throughout the 
United States. This is consistent with additional findings from Holcomb and colleagues 
(2004). They found that from a sample of more than 250 people, a significant amount of 
women (n = 289, 33%) had never heard of HPV.  
In another study, conducted by Moraros and colleagues (2006), only 7% of 
respondents knew that HPV was a virus or STI. Hoover and colleagues (2000) conducted 
a study on HPV vaccine acceptability among adolescents, to evaluate HPV knowledge  
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Table 10 
Research Question and Findings Compared to Previous Research 
Research question Study results Previous research 
1. How accurate is 18- to 26-
year-old women’s knowledge 
regarding cervical cancer, 
HPV, and the HPV vaccine? 
Most women have heard of HPV 
and the HPV vaccine. However, 
they are unsure of its link to 
cervical cancer and genital warts. 
They are also unsure of how to 
decrease their risk of acquiring 
HPV.  
 Agree:  Tiro et al. (2007). 
Holcomb et al. (2004). 
 
Disagree: Moraros et al. 
(2006). 
Hoover et al. (2000) 
2. Do 18- to 26-year-old women 
believe there are severe 
consequences to getting HPV 
and cervical cancer? 
Most women in the current study 
agreed or strongly agreed that there 
are severe consequences to 
contracting HPV and cervical 
cancer.  
Agree: Hoover et al. (2000).  
Hopenhayn et al. (2007).  
 
3. Do 18- to 26-year-old women 
believe they are susceptible to 
getting HPV and cervical 
cancer? 
Women either disagreed or were 
unsure about their susceptibility of 
contracting HPV or cervical cancer, 
based on their family history.  
Agree: Ingledue et al. (2004) 
Denny-Smith et al. (2006).  
 
4. What do 18- to 26-year-old 
women perceive as barriers to 
obtaining the HPV 
vaccination? 
In this study, barriers weren’t 
thoroughly determined. Women 
reported that lack of insurance was 
not a barrier to getting vaccinated.  
Disagree: McGarvey et al. 
(2003).  
5. What do 18- to 26-year-old 
women perceive as benefits to 
obtaining the HPV 
vaccination? 
Women understand the benefits to 
getting Pap screenings. However, 
most reported that they haven’t 
been educated on the benefits to 
vaccination. Thus, their unsure 
attitudes exist.  
Disagree: Hopenhayn et al. 
(2007). 
6. Do 18- to 26 year-old 
women’s knowledge levels 
and attitudes (i.e.,  perceived 
susceptibility, perceived 
severity, perceived barriers, 
and perceived benefits) 
regarding HPV and cervical 
cancer predict their intention 
to receive the HPV 
vaccination? 
According to results of the ordinal 
regression analysis, no significant 
relationships were found using the 
constructs of the Health Belief 
Model (perceived susceptibility, 
perceived severity, perceived 
barriers, and perceived benefits).  
Disagree: Ingledue et al. 
(2004) 
Denny-Smith et al. (2006). 
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and priorities, HPV vaccine acceptability, and willingness to participate in an HPV 
vaccination clinical trial. Although knowledge of HPV was low in this group, women 
were very concerned about cervical cancer and genital warts.  
There are at least two different factors that most likely contributed to the higher 
percentage of women who have heard of HPV in the Bear River Health District. First, the 
national media campaign aimed at promoting the Gardasil vaccine may have attained 
some level of success in raising awareness. Numerous advertisements have aired on 
national television, in print and on the internet for the past few years, stating the benefits 
of the vaccine and the minimal side effects associated with the vaccine.  
Second, consistent with the research findings of Sharpe and colleagues (2005), 
higher knowledge scores may simply be related to a smaller population of lower 
socioeconomic status women in the Bear River Health District. As defined in the HBM, 
demographics and sociopsychological factors may play a large role in study outcomes 
(Rosenstock, 1974). For the present study, it is also crucial to realize that most women 
had either a high school education or some college. There were very few that reported 
having less than high school level education.  
In the current study, a surprising 62% could correctly answer how HPV is 
transmitted from one person to another. Although women seemed to be informed about 
HPV and HPV transmission, an alarming 57.5% could not correctly identify proper ways 
of decreasing their risk of becoming infected with HPV. One explanation of this result 
could be due to the wording of the question: How can you decrease your risk of 
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becoming infected with Human Papillomavirus, and/or possibly confusing response 
choices; 
a. Abstinence (not having sex until married) 
b. Having protected sex with a condom 
c. Avoid smoking  
d. All of the above 
 
Most women reported “Abstinence” as the only correct answer, when in reality, 
they are all correct. As the literature states, practicing safe sex, regular screening tests, 
and HPV vaccination are the best ways to prevent the development of cervical cancer 
(Hayden, 2006).  
  Although religious demographic data was not collected, this result could 
possibly be due to the fact that women of the predominant religion, Latter-Day Saints 
(LDS), have strong beliefs in avoiding sex until marriage. They may feel that avoiding 
sex until marriage will rid all problems related to sex. Some women even wrote 
comments such as that on their completed survey, although there was not a request for 
such comments. Another possibility may be that women felt rushed to complete the 
survey and simply did not read all the answers in their entirety.  
 
Research Question #2: Perceived Severity 
 
When asked if getting HPV is a serious health issue, more than 80% of 
participants strongly agreed or agreed that it is a serious health issue. When asked about 
the seriousness of getting cervical cancer, slightly over 90% of women strongly agreed or 
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agreed that getting cervical cancer is a serious health issue. This result is consistent with 
Hoover and colleagues (2000) and Hopenhayn and colleagues (2007). This researcher 
feels this result is likely due to the nature of the sample, primarily educated White women 
from a more rural area of the nation.  
 
Research Question #3: Perceived Susceptibility 
 
When asked about family history of HPV and cervical cancer, 13.6% either 
strongly agreed or agreed, while slightly over 50% strongly disagreed or disagreed that 
they might be susceptible to HPV and/or cervical cancer. According to the literature 
reviewed in the present study, few studies support this finding. Nonetheless, Ingledue and 
colleagues (2004) conducted a study to better understand college women’s knowledge, 
perceptions and preventative behaviors regarding HVPV infection and cervical cancer. 
This was the only study that applied the Health Belief Model as a theoretical framework 
in determining perceived seriousness, perceived susceptibility and preventative behaviors 
regarding HPV and cervical cancer. Relationships between HPV and cervical cancer 
knowledge and perceived seriousness, perceived susceptibility and preventative 
behaviors were examined. Using Pearson correlation coefficients, no significant 
relationship was found to exist between HPV and cervical cancer knowledge and 
perceived susceptibility to HPV or cervical cancer (r = .020, p = .680). A significant 
negative correlation was found to exist between HPV and cervical cancer knowledge and 
perceived seriousness of HPV and cervical cancer (r = -0.242, p = .000), indicating that 
as knowledge increased, perceived seriousness decreased. The researchers concluded that 
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college women participating in this study demonstrated low levels of knowledge 
concerning HPV and cervical cancer while exhibiting high risk sexual behaviors.  
The current study can compare to that of Ingledue and colleagues (2004), because 
no significant relationship was found to exist between knowledge and perceived 
susceptibility. Although the study design was different among their study, results are still 
comparable. In the present study, the researcher feels that the high amount of women who 
strongly disagreed or disagreed, in regards to their personal susceptibility (50%) is 
somewhat surprising. It is believed that participants may have reported this way, although 
they did not really know their family history. Likewise, it was surprising to discover that 
such a high percentage of women were unsure about their family history. It is important 
to note that women need to know their family history in order to know if they are at risk 
of acquiring HPV and/or cervical cancer. This is a strong predictor of the disease and 
may or may not be preventable. However, if women know their risk, ideally they would 
be more likely to get Pap screenings regularly to avoid acquiring cervical cancer and 
potential early death.   
It is also important to understand that there was only one survey item that sought 
to determine women’s perceived susceptibility in this study. The weakness in the survey 
instrument helped the researcher conclude that having only one survey item doesn’t well 
reflect the construct of perceived susceptibility.  
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Research Question #4: Perceived Barriers 
 
When asked what 18- to 26-year-old women perceive as barriers to obtaining the 
HPV vaccination, this study provided interesting results. To answer this research 
question, subjects were asked if they thought getting the HPV vaccination series might be 
unsafe or harmful to their health. In the current study, 15.6% either strongly agreed or 
agreed and 58.5% either strongly disagreed or disagreed. It is apparent that although 
many women strongly disagree that the HPV vaccine may be unsafe or harmful, others 
(n = 55, 25.9%) were still unsure about the vaccine. This supports past and present 
research that women are still under educated on issues related to cervical cancer, HPV 
and the HPV vaccine.  
Moreover, additional comments were written in by study participants saying that 
they were receiving mixed messages from the media. For example, one participant 
mentioned a recent article on MSNBC that stated the HPV vaccine, Gardasil, may have 
more side effects than are being reported by pharmaceutical companies, physicians, and 
other health care professionals. The researcher was unable to find any research to 
substantiate this claim.  
To determine potential barriers to obtaining the HPV vaccination, another item 
asked about insurance availability and if it explained why women could not or would not 
get the HPV vaccination. Despite findings from McGarvey and colleagues (2003), 
insurance coverage was not reported as a barrier to receiving women’s health care. The 
researcher presumes that HPV vaccination would be categorized as “women’s health 
care,” along with Pap screenings, mammograms, and the like.  
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A few study participants made note on their survey that lack of insurance should 
not be a concern to women living in the Bear River Health District, because the HPV 
vaccine is offered to uninsured women at the Bear River Health Department at minimal 
or no cost. It is believed that these comments were written by participants who actually 
took the survey at one of the Bear River Health Department clinics in the district.  
 
Research Question #5: Perceived Benefits 
 
In order to answer this research question, women were asked what they perceived 
as benefits to obtaining the HPV vaccination. The first question stated, “Getting regular 
pap screenings is beneficial and can detect HPV and cervical cancer.”  The majority of 
the sample (n =179, 84.5%) strongly agreed or agreed with this item, while 6.1% strongly 
disagreed or disagreed. It seems apparent that women are aware of the benefits of 
screening, but they lack knowledge in other areas of preventative women’s health. This is 
likely due to the media, educational levels, and/or personal values.  
The other survey item designed to answer this question read, “I have been 
informed about the benefits of getting the HPV vaccine from a physician or other health 
care professional.”  Results showed that 56.1% of the study sample was uninformed, or 
answered no to the question. The remaining 43.9% reported that they had been informed 
about the benefits of receiving the HPV vaccine from a physician or other health care 
professional. When Hopenhayn and colleagues (2007) conducted a similar study in 
Kentucky, they found similar results. Women in their study (n = 629, 44.4%) had heard 
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of HPV either through media or their health care professional. This supports the notion 
that people likely depend on health care professionals for preventative health education.  
A possible explanation to this finding is that physicians may have serious time 
constraints when dealing with their patients. If physicians were able to be more 
personable and interested in educating women about the vaccines benefits, then women 
might be more likely to obtain the HPV vaccination series.  
 
Research Question #6: Vaccination Intentions 
 
Survey item twenty asked, “Do 18 to 26- year-old women’s knowledge levels and 
attitudes (i.e., perceived susceptibility, perceived severity, perceived barriers, and 
perceived benefits) regarding HPV and cervical cancer predict their intention to receive 
the HPV vaccination”? In order to answer this question, a PLUM ordinal regression was 
conducted.  
Results from the analysis indicate that there were no statistically significant 
differences or results produced from the present study. This is inconsistent with many 
studies discussed in the literature reviewed for the current study. Possible reasons for this 
inconsistent result are explained in further detail in the next section.  
 
Implications for Health Education 
 
Although this study did not conclude with any findings of statistical significance, 
some important results were identified. These findings are important for health educators 
and health professionals, specifically those dealing with women.  
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The most noteworthy data from the current study were that a large number of 
women (n = 81, 38.2%) are still unsure about their likelihood of getting the HPV 
vaccination despite their knowledge level. Despite marketing efforts, this study 
concluded that little education is being provided to women in the heath care setting. It 
might be due to a number of factors, including time and/or financial constraints.  
Another item of interest to the researcher is that women of this sample expressed 
that they might be somewhat dependent on advice provided by their physician or health 
care provider. More than half of the women in the study (56%) reported that they had not 
heard of the vaccine benefits from their health care provider. This is important for health 
educators in program planning and implementation in order to better collaborate with 
women’s health professionals. Collaboration is utmost important for heath educators, as 
that is often times the only way to get challenging objectives accomplished.  
Another implication discovered in this study is the possible weakness of the 
theoretical model (HBM) in predicting health behaviors. According to Janz, Champion, 
and Strecher (2002), one of the most notable weaknesses of the HBM has been 
inconsistent measurement of the concepts in both descriptive and intervention research. 
The vast majority of studies using the HBM fail to establish validity and reliability prior 
to testing the model. Although the survey instrument used in this study was reviewed 
prior to model testing, there may have been weaknesses in the design that were never 
identified by the researcher nor the expert panel. It has been advised that researchers 
should always seek out valid and reliable instruments before they proceed to develop 
their own. In this study, the researcher designed the survey instrument based on a variety 
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of others. This may be another weakness in the current study and likely affected the 
outcomes of this research.  
In regards to the survey instrument, the last weakness determined by the 
researcher is that not all of the HBM constructs had more than one survey item. Janz and 
colleagues (2002) recommended that multiple items should be developed for each scale 
or construct in order to avoid measurement error. This includes the addition of behavioral 
anchors and even items such as self-efficacy and cues to action, both of which were 
excluded from this study. As was mentioned before, having only one perceived 
susceptibility survey item simply was not enough to fully reflect this construct of the 
HBM. 
 
Future Research 
 
Researchers utilizing the HBM should consider using a combination of models or 
frameworks. This is simply because behavioral outcomes are usually complementary 
with significant degrees of overlap. Nonetheless, the HBM should be tested as a 
collection of constructs, not as a collection of equally weighted variables operating 
simultaneously. Furthermore, future research should be conducted with various groups of 
women. This study was successful at reaching women in various clinics in the Bear River 
Health District, but the majority of the sample was White women with some college 
education.  
Nonetheless, as recommended in the previous section, the current survey 
instrument should be reevaluated and designed to better meet the needs of the HBM. 
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There are a limited amount of surveys from past research that would aid future 
researchers in this process.  
Additionally, this study required women to self-report their knowledge and 
attitudes towards cervical cancer, HPV and the HPV vaccine. Self-report measures are 
always concerning in quantitative research. The researcher of the current study suggests 
future research geared towards qualitative studies, including the use of focus groups and 
interviews among women ages 18-to 26-years old.  
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Women’s Health Survey 
 
Answer the following questions honestly and to the best of your ability 
Circle only one answer 
 
 
(1) How old are you? 
 
 
(2) Are you pregnant? 
 
a. Yes 
b. No 
c. Don’t Know 
 
 
(3) What is your race/ethnicity? 
 
a. Caucasian 
b. Non-white Hispanic 
c. African American 
d. Asian 
e. Multiracial 
f. Other   
 
 
(4) Please circle your highest level of education completed: 
 
a. Less than high school 
b. High school 
c. Trade school/certification program 
d. Some college 
e. Bachelor’s degree 
f. Post graduate degree 
 
 
(5) Have you heard of the Human Papillomavirus (HPV)? 
 
a. Yes 
b. No  
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(6) How is Human Papillomavirus transmitted from one person to another? 
 
a.  Sexual contact 
b.  Sharing a drink with someone 
c.  Through needles 
d.  Don’t know 
 
 
(7) How can you decrease your risk of becoming infected with Human Papillomavirus? 
 
e. Abstinence (not having sex until married) 
f. Having protected sex with a condom 
g. Avoid smoking  
h. All of the above 
 
 
(8) Human Papillomavirus is linked to genital warts and cervical cancer? 
 
a. True 
b. False         
 
 
(9) How can you prevent yourself from acquiring cervical cancer?  
 
a. Practicing safe sex 
b. Getting regular pap test screenings 
c. Vaccination 
d. All of the above 
 
 
(10) Have you heard of a vaccine that protects women from becoming infected with common 
strains of Human Papillomavirus? 
 
a. Yes 
b. No 
 
 
Rate the statements below using the following scale: 
 
 
1= Strongly Disagree   2= Disagree   3= Not sure   4= Agree   5= Strongly Agree 
  
(11) My family history puts me at risk for getting cervical cancer and/or HPV.  
1       2       3       4       5 
 
(12) Getting HPV is a serious health issue.  
1      2       3       4       5 
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(13) Getting cervical cancer is a serious health issue.  
1       2       3       4       5 
 
(14) There is always something that holds me back from getting annual Pap screenings.  
1       2       3       4       5 
 
(15) Getting regular Pap screenings is beneficial and can detect HPV & cervical cancer. 
1       2       3       4       5 
 
(16) I think getting the HPV vaccination series might be unsafe or harmful to my health. 
1       2       3       4       5 
 
(17) I believe in the innovative HPV vaccine as a means to prevent HPV infection.  
1       2       3       4       5 
 
(18) I have, or will have received the HPV vaccination series within the next nine months. 
1       2       3       4       5 
 
(19) Lack of insurance explains why I cannot or will not get the HPV vaccine. 
1       2       3       4       5 
 
(20) I have been informed about the benefits of getting the HPV vaccine from a physician or other 
health care professional? 
 
a. Yes 
b. No 
 
 
 
 
 
 
Thank you for your time and honesty. This research will 
help in improving women’s health education! 
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LETTER OF INFORMATION 
Determining the Knowledge & Attitudes of Women Regarding Cervical Cancer 
 
Introduction/Purpose:  Assistant Professor Phillip Waite in the Department of Health, 
Physical Education and Recreation at Utah State University (USU) and Ashlee Cooper, 
Research Assistant, are conducting a research study to find out more about women’s 
beliefs regarding the new vaccine predicted to prevent certain strains of Human 
Papillomavirus (HPV), which may lead to cervical cancer. Women who are between the 
age of 18-26 will be asked to participate because they fall into the target population of 
women who should be getting this vaccine Approximately 210-225 participants will be 
involved in this study.  
 
Procedures:  If you agree to participate in this research, you will be asked to complete an 
anonymous survey which may take approximately five minutes to complete. Please do 
not put your name or any identifiable information on this survey. When you have 
completed the survey, please put it in the envelope provided and seal it and then place it 
in the drop box located in the main office at the front desk. If you are pregnant you will 
not be asked to participate because the vaccine is not recommended for pregnant women 
at this time.  
 
Risks:  There is minimal risk in participating in this study. However; if you have 
concerns you may ask questions to your physician. 
 
Benefits:  Participation in this research may not have a direct benefit to you at this time; 
however, the researchers may be able to collect information which may assist health 
professionals to better understand women’s attitudes towards their health and possibly 
determine their intentions to get vaccinated against HPV. 
 
Voluntary Nature of Participation and Right to Withdraw without Consequence:  
Participation in this study is entirely voluntary. You may withdraw at anytime without 
consequence. 
 
Confidentiality:  No personal identifiable information is being asked. The survey is 
completely anonymous and no one will know how you answered the questions. Placing 
the completed survey in the envelope provided and sealing it will allow us to keep this 
study anonymous. 
 
IRB Approval Statement:  The Institutional Review Board for the protection of human 
participants at USU has approved this research study. If you have any questions or 
concerns about your rights, you may contact the IRB at (435) 797-1821.  
_______________________________  ______________________________ 
Phillip J. Waite, Ph.D.    Ashlee Cooper, BS, CHES  
Major Professor     Student Researcher                 
(435) 797-7217     (435) 757-5547
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Dear Cache Valley Women’s Center: 
 
My name is Ashlee Cooper and I’m a graduate student of Utah State University. I am 
strongly interested in determining the knowledge, attitudes and beliefs of 18-26 year old 
women in the Cache Valley area regarding the new HPV vaccination series that is 
predicted to prevent HPV and cervical cancer. This research would be used for a Master’s 
Thesis in the Department of Health, Physical Education and Recreation.  
 
Ideally, my hopes are to administer a brief, confidential and anonymous survey to your 
patients at the Cache Valley Women’s Center. This survey would be completed, 
voluntarily, as the patient fills out their medical history/update forms in your waiting 
room. This research would begin in February 2008 and conclude in May 2008 if all goes 
as expected. Again, these surveys would be anonymous and used for research purposes 
only.  
 
Patients would be given an Informed Consent Form and be made aware of the purpose of 
the study prior to completing the survey. I strongly believe this process is possible, but 
would require some commitment from the front office staff (gathering and keeping track 
of surveys) and I am willing to work with you in any way possible.  
 
In summary, understanding the knowledge, attitudes and beliefs of 18-26 year old women 
in Cache Valley is significant in order to improve women’s health issues in our 
community. I would be happy to meet with you during your regularly scheduled staff 
meetings or another appropriate time to answer further questions that you may have. I 
look forward to your response and hope you will strongly consider the proposed research 
study. 
 
Sincerely, 
 
 
 
Ashlee Cooper, BS, CHES 
Graduate Assistant 
Department of Health, Physical Education & Recreation 
Cell: 435-757-5547 
E-Mail: a.cooper@aggiemail.usu.edu 
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